Objectives To identify the type of services currently provided by community pharmacists and to explore the barriers for providing high-quality services within the community pharmacy sector in Jordan. Methods Using random sampling technique, pharmacies were approached to take part in this questionnaire-based research. All the collected data were analysed using PASW â 18.0. Correlations were studied using Pearson's correlation. Key findings From the 714 community pharmacies that were approached, 374 pharmacists were responded to the survey 52.4%. The majority of pharmacies provided patient counselling for long-term conditions and weight management (72.5%, n = 271 and 70.3%, n = 263 respectively). Lack of patient interest was the main barrier for not providing pharmaceutical services according to 50.8% of pharmacists. Three-quarters of the pharmacists preferred to be given incentives for providing pharmaceutical services by government (73.3%, n = 274). There were significant correlations between providing community pharmacy services and subspecialty of the responding pharmacists (r = 0.142, P < 0.01), experience (r = 0.150, P < 0.01). Concerns regarding patient adherence to medications were raised by 88% of pharmacists. There was a significant positive correlation between subspecialty and concerns about adherence (r = À0.160, P < 0.01), on the other hand, significant negative correlation was found between years of experience and concerns about adherence (r = À0.246, P < 0.01).
Introduction
The pharmacist's role has evolved over time; from being a role solely of supplier of medicines to being a provider of health care and health services. Pharmacist's responsibilities include ensuring that a patient's drug therapy is appropriately and effectively managed and includes by providing patient counselling. Patient counselling is a critical component of the dispensing process and has been described as: 'providing medication information orally or in written form to the patients or their representatives on directions of use, advice on side effects, precautions, storage, diet and lifestyle modifications'. [1] Poor patient counselling can lead to inappropriate medication usage, including non-adherence, which is considered as one of the major constraints of health care, whereas appropriate patient counselling has been reported to result in better medication adherence and compliance [2] and has an important role in reducing anxiety and increasing patient satisfaction levels. [3] Barriers to effective pharmaceutical care services exist. Studies have found that there was insufficient pharmacist time to complete these pharmaceutical services, in addition to other factors including large numbers of patients per pharmacist. [4] Barriers can be complex, such as low financial resources which might lead to understaffing. [5] Moreover, lack of private areas for use during counselling can be a barrier for continued patient counselling. [4] It is important to evaluate the type of pharmaceutical services, the quality of these services and the barriers that exist in select countries. This enables policymakers to better understand what services are being offered and to explore the obstacles that may hinder quality services being performed. However, research surrounding the type and the quality of pharmaceutical services in low-and middleincome countries is limited. [6] Hasana et al. evaluated community pharmacy services in the United Arab Emirates (UAE), and found that professional patient counselling and services were not provided in most pharmacies. A very low percentage of pharmacies provided screening services, such as blood sugar testing, and patient records were not stored in most pharmacies. The authors concluded that the type and frequency of services must be improved. [7] The role of community pharmacies in Jordan, UAE and Iraq was explored by Basheti et al. This study revealed that majority of patients in Jordan and Iraq considered a pharmacy to be the major contributor of healthcare services. Patients in the UAE, on the other hand, referred to specialists for such services. This discrepancy could possibly stem from socio-economic differences between the countries. [8] Sweileh et al. in 2014 concluded that there is a low emphasis on community pharmacy research in Middle Eastern Arab countries. [9] These studies highlight the need for future research on this topic.
Jordan has more than 2893 [10] community pharmacies distributed throughout the country and the role of the pharmacist within Jordan has been discussed in the literature to some degree. Jarab et al. [11] emphasized the importance of the pharmacist's role in the management of diabetes mellitus in Jordan. Patients who received professional and intensive education showed good control and improved biomarkers, including glycosylated haemoglobin, compared to patients who did not receive this service. Moreover, Abu Ruz et al. evaluated the understanding of pharmaceutical care by pharmacists in Jordan and found that the definition of pharmaceutical care and the pharmacist's role were recognised by more than 70% of the study sample. [12] However, to date, no studies have investigated the pharmaceutical services provided by pharmacies in Jordan in the community pharmacy setting, including patient counselling services. The only published study from Jordan that centred on patient counselling was in a hospital setting. [13] Therefore, there is an urgent need for a National study in order to understand the type and quality of pharmacy services being offered in the community and to understand the potential barriers that may exist for patient counselling and other Pharmacy services provided to public in Jordan.
The objective of this study was to provide baseline information and perspectives of community pharmacies in Jordan, in order to inform policymakers and to raise awareness of the services that pharmacists provide in their daily practice. Second objective was to assess the quality of current community pharmacy services and find out if there any barriers or obstacles to providing high-quality services.
Methods

Sample-size calculation
Based on the sample-size calculation table from Krejcie and Morgan [14] from total of 2893 community pharmacies, [10] a minimum of 340 sites would be needed to achieve a 95% level of confidence. Due to the uptake of questionnaire-based research being relatively low, a 50% response rate was anticipated and a 5% margin was factored in. Therefore, a random selection of 714 pharmacies was contacted to complete the questionnaire. The calculated 714 Community Pharmacies were randomly selected to participate in this survey by using Microsoft Excel randomization software. The addresses of the Community Pharmacies were obtained from the Jordan Pharmaceutical Association. Each pharmacy was only approached to complete one questionnaire, regardless of the number of pharmacists that were employed.
Subjects and sampling procedure
This study was approved by the Institutional Review Board at the Hashemite University/Jordan. The study was conducted from April to August 2016 in the form of a selfadministered questionnaire. The participation in this study was strictly voluntary, and the informed consent of the participants was obtained. The anonymity of the respondents was preserved in the study, as the names of the participants were not included. All the participating pharmacists signed an informed consent relating to the confidentiality of the collected data before their participation. No incentive was provided for participation.
Consenting Pharmacists could choose to complete the questionnaire on the spot or at a later date, in which case they were revisited after 2 weeks to obtain their responses. Pharmacists who failed to complete the questionnaire within the first week were revisited after a further 2 weeks.
Questionnaire design
The questionnaire was developed after reviewing the literature, [4, 5, 7] and also by using the International Pharmaceutical Federation's Standards for Quality of Pharmacy ServicesGood Pharmacy Practice, [15] and the Australian National Pharmacy Database Project reported by Berbatis et al. [16] Evaluation of the final version of the questionnaire by experts (two academics and two Pharmacists) indicated that it had appropriate content validity. A pretest on a convenience sample of 20 Pharmacists was carried out and minor amendments to the wording of the questionnaire were made to enhance its ease of comprehension and clarity. Cronbach's alpha of the different sections of the questionnaire was over 0.8, indicating that each subscale of the questionnaire had very good reliability for use in survey research. The final version of the questionnaire comprised of three different sections. The first section was designed to investigate the current professional services provided and patient counselling barriers and challenges of providing services and patient counselling in the Community Pharmacy. In the second section, Pharmacists were asked about the type of product supplied at their Community Pharmacy. The third section of the questionnaire, collect respondents' demographics and other general information.
Data analysis
All the collected data were analysed using PASW â 18.0 (SPSS Inc., Chicago, IL) and Microsoft Excel. Relations between demographics and response were studied using Pearson's correlation.
Results
Seven hundred and fourteen questionnaires were distributed and 400 questionnaires were returned and only 374 usable questionnaires were included (response rate = 52.4%).
Demographics
The demographic data of the respondents are presented in Table 1 . Females accounted for 60.2% (n = 225) of the study sample. Around 63.9% (n = 239) of pharmacists had practical experience of 5 years or less. Only 8.3% (n = 31) of the participants graduated from non-Arab countries. The majority of community pharmacies in this study were independent owners and not part of a chain 70.6% (n = 264).
Current professional services and barriers to these services
The fields in which pharmacists provided patient counselling services are shown in Table 2 ; 72.5% of community pharmacists counselled patients with long-term conditions, compared with only 23.0% who provided counselling on sexually transmitted diseases. Significant correlations were found between providing community pharmacy services and subspecialty of the responding pharmacists (r = 0.142, P < 0.01), years of experience (r = 0.150, P < 0.01) and country of qualification pharmacy services (r = 0.111, P < 0.05).
The majority of community pharmacists (88%) raised concern regarding patient adherence to medication. There was a significant positive correlation between subspecialty of the responding pharmacists and concerns about adherence (r = À0.160, P < 0.01), on the other hand a significant negative correlation was found between years of experience and concern about adherence (r = À0.246, P < 0.01).
The most common cause of patient non-adherence according to 43.6% of pharmacists are the side effects of the medication, with forgetfulness being the second most common (33.4%). The presence of certain patient factor (dysphagia, caregiver, parenteral route of administration) reported as a cause of non-adherence by only 23.0% (n = 86) of the community pharmacists ( Figure 1) .
Half of the respondents (51.1%) reported they would choose another dosage form for the patient, if the patient complained from dysphagia. More than one-third of the pharmacists (35.6%) will consult the patient's prescriber. Only 9.4% of the respondents will extemporaneously compound a preparation (special compounding) and 4% of pharmacists will do nothing ( Figure 2) .
The preferred method used with patients to provide Patient counselling was face-to-face oral patient counselling, with 92.5% of pharmacists expressing this option. Use of extra precautionary labels, for example. Take with food, don't drive was done according to half of the pharmacists (49.5%). Patient information leaflets or other written or printed material was used by 37.7% of the pharmacists. Counselling over the phone was also used in Jordan and reported by (27.3%) of the responders. Pharmacists also referred patients to physicians according to 19.3% of the pharmacists. Only 5.3% use e-mails or social media to give pharmaceutical care services ( Table 3) .
As represented in Figure 3 , community pharmacists provide patient counselling for newly prescribed medication and each refill prescription according to 62.0% of respondents.
The devices used by community pharmacist to monitor patient as a disease prevention method or routine clinical testing are presented in Table 4 below. The most frequently used devices were the sphygmomanometer, weight scale and glucometer with 79.4% (n = 297), 75.9% (n = 284) and 74.6% (n = 279) respectively. Portable INR (International Normalized Ratio) devices were used by only 1.3% (n = 5) of respondents. Barriers for not providing Pharmaceutical care services at community pharmacy are presented in Table 5 below, half of the pharmacists (50.8%) stated that they would not provide such service due to factors related to the patient (e.g. lack of interest).
As presented in Figure 4 below, three-quarters of respondents would prefer the Government to give incentives for providing pharmaceutical services at community pharmacy (73.3%).
Products offered by pharmacies
As seen from Table 6 below, specialized compounding and smoking cessation products are available in only 58% and 60.2% of community pharmacy respectively. And all other products in the survey were available in more than 86.4%.
Discussion
It is imperative to evaluate services that are provided in the community by pharmacies. Low-and middle-income countries are no exception; this is highlighted by Basheti et al. [8] who reported that patients in Jordan and Iraq perceived pharmacies to be a central health service. To date, the information regarding the services and barriers to these services in Jordan was limited. Whilst some studies have shown that discrete pharmaceutical services provide benefit to patients, for example, Jarab et al. who focused on patients with diabetes, [11] there has been no study that has attempted to evaluate overall what services community pharmacies provide and perceived barriers to these services. The most common causes of noncompliance: Figure 1 Pharmacists perceptions about causes of non-compliance in Jordan. Pharmacists action for a patient complained from dysphagia: Figure 2 Pharmacists action in case of dysphagia. The results of this study have illustrated that most pharmacies in Jordan provide a wide range of pharmaceutical services and patient counselling especially for long-term conditions. About three-quarters (72.5%) of responded community pharmacists provide counselling for patients with long-term conditions. A study conducted in 2014 [17] evaluated the impact of patient counselling in hypertensive patients and found that the pharmacist can have an effective role in the management of hypertension. There was a significant increase in patient knowledge of the disease, including signs and symptoms after receiving pharmacists' counselling, which led to more adherence to hypertension medications resulted in better health outcomes in terms of blood pressure control and medication compliance. On the other hand, another recent study conducted in Kuwait in 2017 found low adherence with low statin drugs was associated with higher levels of plasma cholesterol. [18] In the present study, 70% of pharmacists in Jordan gave patient counselling regarding weight management, one report found that the overall prevalence of overweight in Jordan was 30% and obesity was 38.8% among Jordanian women aged 15-49 years. [19] This highlights that pharmacists could potentially have a positive impact with regard to weight management and obesity.
On the other hand, only 23% of the pharmacists provided patient counselling in regard to sexually transmitted Agree with the implementation of service fee Disagree with the implementation of service fee
Pharmacists perception regarding incentives for providing pharmaceutical care services by government: Figure 4 Pharmacists' opinion about implementing services fee in Jordan. Currently, pharmacists provide counselling for patient with: Figure 3 Type of prescriptions in which pharmacists provide counselling. diseases. This could be due to low prevalence of sexually transmitted infections detected in Jordan. Mahafzah et al. [20] found that the prevalence of Chlamydia trachomatis infection was 0.6% and 0.5%, among symptomatic and asymptomatic women respectively that of Neisseria gonorrhoeae was 0.9% and 2.2%, that of Treonema pallidum 0.0% and 0.0%, and that of Trichomonas vaginalis was 0.7% and 0.5%. [20] Another reason due to cultural perceptions of discussing sexual transmitted diseases and low number of pharmacists that provided patient counselling relating to sexually transmitted diseases in Jordan could be due to the low experience of the participants of this study as 63.9% (n = 239) of pharmacists had practice experience of 5 years or less. The preferred method of pharmaceutical care services used in Jordan was face-to-face oral patient counselling according to 92.5% of pharmacists. Face-to-face counselling sessions with a community pharmacist have a positive impact on patient compliance. It was found earlier in 2012 that patients who participated in brief face-to-face counselling at the beginning of statin therapy demonstrated greater medication adherence and persistency than another group. [2] Similarly, to what was found with UAE pharmacists, [7] the use of extra small precautionary labels, for example Take with food, don't drive was used by almost half of the Jordanian pharmacists.
Community pharmacists in Jordan provide patient counselling for both newly prescribed medications and each refill prescription according to two-thirds of the participant pharmacists. According to American National Association of Boards of Pharmacy, the counselling for the newly prescribed was compulsory, and for the refills prescriptions it is according to pharmacist professional judgement in some state, and compulsory for others. [21] The main barrier identified for not providing pharmaceutical care services at community pharmacy of Jordan was patient-related factors, such as lack of patient interest. This is in line with previous researchers that reported the lack of patient interest and the low level of education can be a barrier to counselling process. [22] Three-quarters of the pharmacists preferred the Government to give incentives for providing pharmaceutical services in community pharmacy. The professional responsibility of the Pharmacists should include, in addition to the dispensing of medicines, patient counselling and advice on how to use medicines correctly as well as the maintenance of patients' records. This could be reflected by introducing a Remuneration fee. This incentive is applicable worldwide. Bernsten et al. studied the professional service fee payment across countries, and they found that there is a service fee applied in the following countries; Australia, Belgium, Canada, Denmark, Ireland, Portugal, Switzerland, the United Kingdom, and the United States. [23] Adherence is defined as the extent to which medication intake behaviour corresponds with the recommendations of the healthcare provider. [24] It was found that patients who received verbal and written information were found to adhere better with their drug regimens, to make fewer errors and to remember more information about their medications than patients who did not discuss their drugs with the clinical pharmacist. [25] The community pharmacist can help to increase compliance with drug regimens by providing patients with additional information about individual drugs, identifying potential adverse drug reactions and interactions, and supplying appropriate drug containers or adherence aids. [26] In order to improve compliance, many strategies must be employed including counselling, patient education and memory enhancement. [27] Pharmaceutical counselling is a critical task which can be carried out by the pharmacists in every clinical practice setting, by providing the patients with the knowledge and in some instances, the skills to effectively handle their medical condition. [28] Determining patient non-compliance and making adjustments to patient education will enable pharmacists to expand their professional role while improving patient outcomes. [28] The most common causes of non-adherence in Jordan according to 43.6% of Pharmacists are the side effects of the medication. This is similar to the results of a systematic review conducted in 2017. [29] Forgetfulness was the second non-adherence reason according to 33.4% of the Jordanian Pharmacists and side effects of the medication the first. However, in a previous study, conducted in 2011, on hypertensive patients, forgetfulness and being too busy were the most common reasons given for non-adherence, and the side effects of the medication wereas the second reason. [30] 
Conclusion
This study explores the type and extent of professional services provided through community pharmacies in Jordan and provides baseline data critical to inform the policymakers on how to improve the delivery of enhanced professional services, what other services should be implemented in order to increase patients' adherence which results in better health outcomes. The most commonly reported barrier for patient counselling was the lack of interest from patients, which can be minimized by implementing special awareness sessions to the public on the importance of receiving counselling from pharmacists and its role in improving patient adherence which leads to better health outcomes. Training programs teaching pharmacists to how to deal with lack of interest patients and to encourage patients to share experiences using therapy, how to build a therapeutic alliance with patients in order to mutually understand the goals of therapy and develop self-awareness of the personal effects on patients. Future studies evaluating community pharmacy services from the patients and physicians' perspectives should be conducted. Similar to many worldwide countries, incentives should be given to Jordanian Pharmacists for their significance role in providing Pharmaceutical Services and patient education in the Community Pharmacy.
Limitations of the study
The main limitation of questionnaire-based studies in general and this particular study, that the researchers do not have the opportunity to fellow up with participants idea deeply to explain the underlying reasons for not providing community pharmacy services. Moreover, the structure of the questionnaire may force the participating pharmacist to answer fixed questions that reflect researchers' perspectives. Therefore, a future qualitative interview study with community pharmacists should discuss the main barriers of providing pharmaceutical services and how to overcome these barriers should be followed to complement with this study.
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